Document is current
Any future updates will be listed below
-
Authors
Moreno-Navarro, Luis https://orcid.org/0000-0002-7550-6239
Mora-Diaz, Sergio https://orcid.org/0000-0002-4646-0729
Ruiz-Escribano-Menchen, Lourdes https://orcid.org/0000-0003-0746-1005
Sempere, Angel P. https://orcid.org/0000-0002-0195-2834
- License Information
-
More Information
Article History
Received: 5 August 2025
Revised: 2 September 2025
Accepted: 7 September 2025
First Online: 23 September 2025
Declarations
:
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: LMN has received speaking honoraria or travel expenses for participation in scientific meetings from AbbVie, Esteve, Kern Pharma, Merck, Neuraxpharm, Novartis, Roche, Sandoz, and Sanofi. SMD has no conflicts of interest. LREM declares fees for lectures or assistance to congresses from Alter, Bristol Myers Squibb, Daiichi Sankyo, Merck, Novartis, and Roche. APS has received personal compensation from Merck Serono, Novartis, Roche, and Sandoz for serving on a scientific advisory board or speaking.
: This study received ethical approval from the Ethics Committee for Medical Research (IRB) of the Health Department of Alicante–General Hospital in Alicante, Spain (approval PI2024-014) on March 28, 2024. This is an IRB-approved retrospective study, all patient information was de-identified and patient consent was not required. Patient data will not be shared with third parties.
: Not applicable.
